Community-acquired pneumonia primary prevention: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Community-acquired pneumonia}} | {{Community-acquired pneumonia}} | ||
{{CMG}}; {{AE}} {{AL}} | |||
==Overview== | ==Overview== | ||
There are several ways to prevent infectious pneumonia. Appropriately treating underlying illnesses (such as AIDS), smoking cessation, vaccination against pneumococcal and influenza are the commonly used methods. | There are several ways to prevent infectious pneumonia. Appropriately treating underlying illnesses (such as AIDS), smoking cessation, vaccination against pneumococcal and influenza are the commonly used methods. | ||
Revision as of 15:43, 10 December 2014
|
Community-Acquired Pneumonia Microchapters |
|
Differentiating Community-acquired pneumonia from other Diseases |
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Community-acquired pneumonia primary prevention On the Web |
|
American Roentgen Ray Society Images of Community-acquired pneumonia primary prevention |
|
Directions to Hospitals Treating Community-acquired pneumonia |
|
Risk calculators and risk factors for Community-acquired pneumonia primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Alejandro Lemor, M.D. [2]
Overview
There are several ways to prevent infectious pneumonia. Appropriately treating underlying illnesses (such as AIDS), smoking cessation, vaccination against pneumococcal and influenza are the commonly used methods.
Vaccination
| Vaccine | Route of Administration | Type of Vaccine | Recommended Groups | Specific high-risk indications for vaccination | Re-vaccination schedule |
|---|---|---|---|---|---|
| Pneumococcal Vaccine | Intramuscular injection | Pneumococcal polysaccharide vaccine | All persons > 65 years of age, high-risk persons 2–64 years of age, current smokers | Chronic cardiovascular, pulmonary, renal, or liver disease, diabetes mellitus, cerebrospinal fluid leaks, alcoholism, asplenia, immunocompromising conditions/medications, native Americans and Alaska natives, long-term care facility residents Residence | One-time revaccination after 5 years for:
|
| Inactivated Influenza Vaccine | Intramuscular injection | Killed virus | All persons > 50 years of age, High-risk persons 6 months–49 years of age, household contacts of high-risk
persons, health care providers, children 6–23 months of age |
Chronic cardiovascular or pulmonary disease (including asthma), Chronic metabolic disease (including diabetes mellitus), Renal dysfunction, Hemoglobinopathies, Immunocompromising conditions/medications, Compromised respiratory function or increased aspiration risk, pregnancy, aspirin therapy in persons < 18 years of age | Annualy |
| Live Attenuated Influenza Vaccine | Intranasal spray | Live virus | Healthy persons 5–49 years of age,a including health care providers and household contacts of high-risk persons | Avoid in high-risk persons | Annualy |
| Adapted from IDSA/ATS Consensus Guidelines on the Vaccine Prevention for Community-Acquired Pneumonia in Adults. [1] | |||||
References
- ↑ Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, Dowell SF, File TM, Musher DM, Niederman MS, Torres A, Whitney CG (2007). "Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults". Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America. 44 Suppl 2: S27–72. doi:10.1086/511159. PMID 17278083. Retrieved 2012-09-06. Unknown parameter
|month=ignored (help)